Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study
These data support an encouraging long-term safety profile of Oleogel-S10 and a sustained reduction in wound burden over at least 24 months of Oleogel-S10 treatment.
Authors
- Dedee Frances Murrell (ORCID: https://orcid.org/0000-0003-2971-0199)
- Mauricio Torres Pradilla (ORCID: https://orcid.org/0000-0002-4826-1248)
- Laura Maher
- Anna L. Bruckner (ORCID: https://orcid.org/0000-0002-2035-4127)
- Johannes Steffen Kern (ORCID: https://orcid.org/0000-0001-6372-8048)
- Tracy Cunningham
- Eli Sprecher (ORCID: https://orcid.org/0000-0002-4093-1032)
- Dimitra Kiritsi (ORCID: https://orcid.org/0000-0002-2331-8981)
- María Emilia Fernández (ORCID: https://orcid.org/0000-0003-1489-5389)
- Charles S. Davis
- Christine Bodemer
Institutions
- University of Freiburg (DE)
- Tel Aviv University (IL)
- Aristotle University of Thessaloniki (GR)
- Tel Aviv Sourasky Medical Center (IL)
- University Medical Center Freiburg (DE)
- UNSW Sydney (AU)
- Institut Necker Enfants Malades (FR)
- Monash Alfred Psychiatry Research centre (AU)
- Cancer Research And Biostatistics (US)
- St George Hospital (AU)
- Fundación Universitaria de Ciencias de la Salud (CO)
- Aqualex Multimedia Consortium (Ireland) (IE)
- St. George Hospital (IN)
- Alfred Health (AU)
- Monash University (AU)
- University of Colorado Denver (US)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1093/bjd/ljaf022
- Citations
- 7
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 8.06
Funders
- Chiesi Farmaceutici
- Amryt Pharma